BioHistory Moment: FDA requested help in removing a hazardous product, "X-33 Water Repellent," from the market
On August 30, 1964, the FDA asked state and local health and safety officials for help in removing "X-33 Water Repellent"
from the market. The extremely flammable product had caused three deaths and more than 30 injuries through flash explosions,
in many cases while it was being used in home basements to waterproof masonry.
Federal oversight of consumer products such as X-33 and many other items used in the home was transferred to the newly
created Consumer Product Safety Commission in 1973. One class of consumer products still regulated by the FDA is
radiation-emitting products.
 More...
Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility
The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses
425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus
cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament
Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Nevada, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
- Halozyme begins phase 2 clinical trial with insulin analogs Lispro and Aspart with rHuPH20 Halozyme Therapeutics announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme in combination with the two leading commercially available mealtime analogs: insulin aspart, NovoLog, and insulin lispro, the active ingredient in Humalog.
Halozyme Therapeutics, Inc. September 02, 2010
- XOMA regains NASDAQ compliance XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
XOMA Ltd. September 02, 2010
- XOMA regains NASDAQ compliance XOMA announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.
XOMA Ltd. September 02, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Nevada's BioHistory
Why is there a life science industry in Nevada? Is the industry
growing? What do other states have?
Through Nevada BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Nevada.
More...
BioEvolution Posters
More...
August: National Immunization Awareness Month
The goal of National Immunization Awareness Month (NIAM) is to increase awareness about immunizations across the life
span, from infants to the elderly.
Immunization is one of the most significant public health achievements of the 20th century. Vaccines have
eradicated smallpox, eliminated wild poliovirus in the U.S. and significantly reduced the number of cases of measles,
diphtheria, rubella, pertussis and other diseases. But despite these efforts, people in the U.S. still die from these
and other vaccine-preventable diseases.
More...
BioFact
(1839) - Congress puts $1,000 into the Congressional Seed Distribution Program, administered by the U.S. Patent Office, to increase the amount of free seeds mailed to anyone requesting them.
It's a Small World
|
| |
Burkholderia Pseudomallei
| |
Science Quote
"One thing I have learned in a long life: that all our science, measured against reality, is primitive and childlike and yet it is the most precious thing we have."
| - |
Albert Einstein
|
|
(1879-1955)
|
|
